Biotech · Private company · Beaverton, OR, US
Najit Technologies, Inc.
Track this companyFree. Adds Najit Technologies, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- HydroVax-002 YFVPhase 1 · Yellow FeverClinicalTrials.gov · fetched Nov 12, 2026
- HydroVax-005 CHIKVPhase 1 · Chikungunya FeverClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Trial of an Inactivated Chikungunya Virus VaccinePHASE1 · COMPLETED · started Nov 4, 2024ClinicalTrials.gov NCT06669208 · fetched Nov 12, 2026
- Trial of an Inactivated Yellow Fever Virus VaccinePHASE1 · COMPLETED · started Jan 13, 2022ClinicalTrials.gov NCT05172544 · fetched Nov 12, 2026
NIH awards3
- A Randomized Phase I Clinical Trial of HydroVax-CHIKV, a Novel Inactivated Chikungunya Virus VaccineFiscal year 2026 · $980.3KNIH RePORTER 5U44AI152995-04 · fetched Nov 12, 2026
- A Randomized Phase I Clinical Trial of HydroVax-CHIKV, a Novel Inactivated Chikungunya Virus VaccineFiscal year 2025 · $981KNIH RePORTER 5U44AI152995-03 · fetched Nov 12, 2026
- A Randomized Phase I Clinical Trial of HydroVax-CHIKV, a Novel Inactivated Chikungunya Virus VaccineFiscal year 2024 · $986.1KNIH RePORTER 4U44AI152995-02 · fetched Nov 12, 2026